HanchorBio Inc. (TPE:7827)
Taiwan · Delayed Price · Currency is TWD 160.00
-1.00 (-0.62%)
At close: Jun 24, 2026
HanchorBio Market Cap
HanchorBio has a market cap or net worth of 21.97 billion as of June 25, 2026.
Market Cap
21.97B
Enterprise Value
21.16B
Revenue
312.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
160.00
Market Cap Chart
Since June 20, 2025, HanchorBio's market cap has increased from 5.52B to 21.97B, an increase of 298.03%. That is a compound annual growth rate of 290.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 21.97B | 90.74% |
| Dec 31, 2025 | 11.52B | 108.67% |
| Jun 20, 2025 | 5.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elixiron Immunotherapeutics (Cayman) Limited | 9.53B |
| Tripartite Therapeutics | 8.49B |
| Intelligene | 6.47B |
| Uwell Biopharma | 6.45B |
| Obigen Pharma | 3.85B |
| Pet Pharm Biotech | 2.87B |
| BIONET Therapeutics | 2.57B |
| FullHope Biomedical | 1.14B |